Two Phase 3 Trials of Baricitinib for Alopecia Areata

  • the BRAVE-AA Investigators

Research output: Contribution to journalArticlepeer-review

377 Scopus citations

Fingerprint

Dive into the research topics of 'Two Phase 3 Trials of Baricitinib for Alopecia Areata'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science